Greville-Heygate et al. [53] detected 53 (2.3%) patients carrying a germline CHEK2 PV/LPV out of 2344 women with early-onset BC and CHEK2-associated tumors showed a worse prognosis. This evidence concerns the gene CHEK2 and breast cancer.